Comment On: Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma

• Zhi-Peng Liu, MD,
• Hai-Su Dai, MD,
• Xing-Xing Su, MD,
• Yi-Shi Yang, MD,
• Xian-Yu Yin, BM,
• Zhi-Yu Chen, MD, PhD

Affiliations

Zhi-Peng Liu, MD

Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Amy Medical University), Chongqing, China.

Hai-Su Dai, MD

Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Amy Medical University), Chongqing, China.

Xing-Xing Su, MD

Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Amy Medical University), Chongqing, China.

Yi-Shi Yang, MD

Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Amy Medical University), Chongqing, China.

Xian-Yu Yin, BM

Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Amy Medical University), Chongqing, China.

Zhi-Yu Chen, MD, PhD

Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Amy Medical University), Chongqing, China.